Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Sep;63(9):1128–1130. doi: 10.1136/ard.2003.013201

Hepatitis B vaccination in children with juvenile idiopathic arthritis

O Kasapcopur 1, F Cullu 1, A Kamburothlu-Gokse 1, H Cam 1, E Akdenizli 1, S Calykan 1, L Sever 1, N Arysoy 1
PMCID: PMC1755134  PMID: 15308522

Abstract

Objectives: To evaluate the responsiveness of children with juvenile idiopathic arthritis (JIA) to hepatitis B vaccination and to determine the most useful vaccination schedule.

Methods: 39 children with JIA were enrolled in the study; all were in remission and negative to serological testing for hepatitis B surface antigen (HbsAg). The control group consisted of 41 healthy children. There were two different vaccination schedules: group I was vaccinated at 0, 1, and 3 months; group II was vaccinated at 0, 1, and 6 months. Positive responsiveness to the vaccine was defined as an anti-hepatitis B antibody titre above 10 mIU/ml.

Results: All the children except one with systemic JIA developed an antibody response. None of the JIA patients experienced a flare up or clinical deterioration related to the vaccination. The antibody levels in children with JIA were significantly lower than in the healthy controls. Comparison of the antibody levels between the two vaccination schedules showed no statistical difference in the controls; in the JIA subjects the group II schedule resulted in a trend to a greater response than the group I schedule (p<0.07). Vaccine responsiveness was not influenced by either methotrexate or prednisolone treatment.

Conclusions: Children with JIA had an adequate response to hepatitis B vaccination and the response was not affected by immunosuppressive treatment. A vaccination schedule at 0, 1, and 6 months seems to be preferable to 0, 1, and 3 months.

Full Text

The Full Text of this article is available as a PDF (50.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avery R. K. Vaccination of the immunosuppressed adult patient with rheumatologic disease. Rheum Dis Clin North Am. 1999 Aug;25(3):567-84, viii. doi: 10.1016/s0889-857x(05)70087-9. [DOI] [PubMed] [Google Scholar]
  2. Davies K., Woo P., British Paediatric Rheumatology Group Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence. Rheumatology (Oxford) 2002 Aug;41(8):937–941. doi: 10.1093/rheumatology/41.8.937. [DOI] [PubMed] [Google Scholar]
  3. Elkayam O., Yaron M., Caspi D. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis. 2002 Jul;61(7):623–625. doi: 10.1136/ard.61.7.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Giannini E. H., Ruperto N., Ravelli A., Lovell D. J., Felson D. T., Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997 Jul;40(7):1202–1209. doi: 10.1002/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  5. Halsey N. A., Moulton L. H., O'Donovan J. C., Walcher J. R., Thoms M. L., Margolis H. S., Krause D. S. Hepatitis B vaccine administered to children and adolescents at yearly intervals. Pediatrics. 1999 Jun;103(6 Pt 1):1243–1247. doi: 10.1542/peds.103.6.1243. [DOI] [PubMed] [Google Scholar]
  6. Kanakoudi-Tsakalidou F., Trachana M., Pratsidou-Gertsi P., Tsitsami E., Kyriazopoulou-Dalaina V. Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy. Clin Exp Rheumatol. 2001 Sep-Oct;19(5):589–594. [PubMed] [Google Scholar]
  7. Kane M. Global programme for control of hepatitis B infection. Vaccine. 1995;13 (Suppl 1):S47–S49. doi: 10.1016/0264-410x(95)80050-n. [DOI] [PubMed] [Google Scholar]
  8. Lemon S. M., Thomas D. L. Vaccines to prevent viral hepatitis. N Engl J Med. 1997 Jan 16;336(3):196–204. doi: 10.1056/NEJM199701163360307. [DOI] [PubMed] [Google Scholar]
  9. Maillefert J. F., Sibilia J., Toussirot E., Vignon E., Eschard J. P., Lorcerie B., Juvin R., Parchin-Geneste N., Piroth C., Wendling D. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) 1999 Oct;38(10):978–983. doi: 10.1093/rheumatology/38.10.978. [DOI] [PubMed] [Google Scholar]
  10. Malleson P. N., Tekano J. L., Scheifele D. W., Weber J. M. Influenza immunization in children with chronic arthritis: a prospective study. J Rheumatol. 1993 Oct;20(10):1769–1773. [PubMed] [Google Scholar]
  11. Ozdogan H., Ruperto N., Kasapçopur O., Bakkaloglu A., Arisoy N., Ozen S., Ugurlu U., Unsal E., Melikoglu M., Paediatric Rheumatology International Trials Organisation The Turkish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol. 2001 Jul-Aug;19(4 Suppl 23):S158–S162. [PubMed] [Google Scholar]
  12. Petty R. E., Southwood T. R., Baum J., Bhettay E., Glass D. N., Manners P., Maldonado-Cocco J., Suarez-Almazor M., Orozco-Alcala J., Prieur A. M. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998 Oct;25(10):1991–1994. [PubMed] [Google Scholar]
  13. Sibilia J., Maillefert J. F. Vaccination and rheumatoid arthritis. Ann Rheum Dis. 2002 Jul;61(7):575–576. doi: 10.1136/ard.61.7.575. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES